Your browser doesn't support javascript.
loading
Thrombophilia testing in patients receiving rivaroxaban or apixaban for the treatment of venous thromboembolism.
Kovacs, Matthew R; Lazo-Langner, Alejandro; Louzada, Martha L; Kovacs, Michael J.
Affiliation
  • Kovacs MR; Department of Medicine, Division of Hematology, University of Western Ontario, London, ON, Canada.
  • Lazo-Langner A; Department of Medicine, Division of Hematology, University of Western Ontario, London, ON, Canada; Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada.
  • Louzada ML; Department of Medicine, Division of Hematology, University of Western Ontario, London, ON, Canada; Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada.
  • Kovacs MJ; Department of Medicine, Division of Hematology, University of Western Ontario, London, ON, Canada. Electronic address: michael.kovacs@lhsc.on.ca.
Thromb Res ; 195: 231-232, 2020 11.
Article in En | MEDLINE | ID: mdl-32799129
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombophilia / Venous Thromboembolism Limits: Humans Language: En Journal: Thromb Res Year: 2020 Document type: Article Affiliation country: Canada
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombophilia / Venous Thromboembolism Limits: Humans Language: En Journal: Thromb Res Year: 2020 Document type: Article Affiliation country: Canada